GlaxoSmithKline PLC Total Voting Rights (3693O)
01 Octubre 2019 - 07:09AM
UK Regulatory
TIDMGSK
RNS Number : 3693O
GlaxoSmithKline PLC
01 October 2019
GlaxoSmithKline plc
Total Voting Rights and Capital
In conformity with the Financial Conduct Authority's Disclosure
Guidance and Transparency Rule 5.6.1R, GlaxoSmithKline plc (the
'Company') hereby notifies the market of the following:
The Company's issued share capital as at 30 September 2019
consisted of 5,382,230,251 shares of 25 pence each ('Ordinary
Shares'), of which 393,505,950 Ordinary Shares were held in
Treasury.
Therefore, the total number of voting rights in the Company is
4,988,724,301. This figure may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change to their
interest in, the Company under the Financial Conduct Authority's
Disclosure Guidance and Transparency Rules.
V A Whyte
Company Secretary
1 October 2019
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
TVRUGGRUUUPBGPG
(END) Dow Jones Newswires
October 01, 2019 08:09 ET (12:09 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024